ResMed Inc. (NYSE:RMD – Get Free Report) CEO Michael J. Farrell sold 14,683 shares of the stock in a transaction dated Friday, June 7th. The stock was sold at an average price of $211.66, for a total transaction of $3,107,803.78. Following the transaction, the chief executive officer now directly owns 440,799 shares of the company’s […]